48

1

Logo

ERC

Company | Belgium
2

followers

1

organizations

Primary tabs

About your organization

ERC has developed a unique advanced cancer cell based immunotherapy invented by Pr. Apostolos Stathopoulos for the treatment of patients suffering from brain cancers. This therapeutic vaccine known as ERC1671 (Gliovac™) particularly targets high grade gliomas.

 

ERC seeks to eliminate cancer cells completely, leading to a cure through its unique cell-based immunotherapy approach that treats patients suffering from glioma or glioblastoma by directly stimulating the patient’s immune system with whole cancer cells and cell extracts. ERC has developed a unique, patented process using whole cells and lysates of autologous (patient’s own tumour) and allogeneic tumour cells (from other individuals).

News

Network (1)

Recent activity

You are not connected

A certain number of contents are hidden from you and you do not benefit from the linking functionalities.

Log in or register to access to the entire contents and functionnalities. Subscription is quick and free.